extravil
trophoblast
evt
migrat
decidua
critic
establish
placent
perfus
dysregul
may
lead
preeclampsia
pe
intrauterin
growth
restrict
iugr
breast
cancer
resist
protein
bcrp
encod
regul
fusion
cytotrophoblast
syncytiotrophoblast
protect
fetu
matern
deriv
xenobiot
inform
bcrp
function
evt
limit
howev
placent
exposur
bacterialvir
infect
lead
bcrp
downregul
syncitiotrophoblast
hypothes
bcrp
involv
regul
evt
function
modul
infectioninflamm
report
besid
syncitiotrophoblast
cytotrophoblast
bcrp
also
express
evt
bcrp
inhibit
evt
cell
migrat
human
evtlik
cell
human
evt
explant
cultur
affect
cell
prolifer
also
shown
bacteriallipopolysaccharid
lp
viral
antigenssingl
strand
rna
ssrna
profound
effect
downregul
bcrp
level
whilst
simultan
increas
migrat
potenti
evtlik
cell
studi
report
novel
function
bcrp
earli
placent
suggest
exposur
evt
matern
infectioninflamm
could
disrupt
migrat
potenti
via
downregul
bcrp
could
neg
influenc
placent
developmentfunct
contribut
exist
obstetr
patholog
neg
impact
pregnanc
outcom
maternalneonat
health
placenta
support
growth
develop
fetu
paramount
success
pregnanc
critic
stage
earli
placent
develop
prolifer
differenti
cytotrophoblast
ct
extravil
trophoblast
evt
ct
origin
tip
chorion
villi
first
grow
establish
cell
column
differenti
result
evt
invad
matern
uterin
tissu
either
decidu
endometrium
inner
myometrium
interstiti
lumen
uterin
spiral
arteri
blood
flow
endovascular
appropri
migrat
evt
essenti
success
pregnanc
matern
decidua
maintain
tight
control
evt
migrat
paracrin
signal
insuffici
invas
result
poor
placent
lead
preeclampsia
pe
intrauterin
growth
restrict
iugr
seriou
obstetr
complic
convers
uncontrol
evt
migrationinvas
lead
deeper
penetr
trophoblast
myometrium
rather
decidua
basali
placenta
acreta
even
uteru
affect
surround
organ
placenta
percreta
result
maternalfet
morbid
mortal
certain
circumst
uncontrol
trophoblast
prolifer
invas
lead
choriocarcinoma
transmembran
efflux
transport
breast
cancer
resist
protein
bcrp
encod
gene
belong
atpbind
cassett
abc
transport
superfamili
primarili
local
apic
brushbord
membran
syncytiotrophoblast
st
barrier
bcrp
regul
ct
fusion
st
provid
embryofet
protect
drug
environment
toxin
present
matern
circul
st
bcrp
prevent
transfer
number
drug
matern
fetal
circul
therefor
consid
import
fetal
gatekeep
throughout
pregnanc
previous
report
human
placent
bcrp
express
increas
advanc
gestat
peak
term
importantli
viral
bacteri
challeng
patholog
inflammatori
state
alter
placent
bcrp
express
differ
lipopolysaccharid
lp
model
bacteri
infect
decreas
bcrp
express
first
trimest
human
placent
explant
third
trimest
explant
wherea
polyinosin
polycytidyl
acid
poli
c
doublestrand
viral
antigen
induc
chang
bcrp
express
sharp
contrast
placenta
preterm
pregnanc
complic
chorioamnion
exhibit
increas
bcrp
express
indic
natur
sourc
time
gestat
age
infectioninflamm
determin
posit
neg
effect
regul
bcrp
express
consequ
potenti
fetal
exposur
harm
bcrp
substrat
bcrp
express
elev
stem
cell
cancer
cell
bcrp
membran
efflux
protein
role
regul
cancer
cell
function
cell
prolifer
migrationinvas
also
establish
studi
shown
bcrp
induc
cancer
cell
prolifer
migrationinvas
togeth
data
suggest
infect
inflamm
modul
express
bcrp
placent
trophoblast
earli
gestat
alter
level
bcrp
may
affect
migrat
invas
potenti
cell
therebi
caus
pregnanc
complic
though
date
studi
test
hypothesi
given
rel
high
incid
bacteri
viral
infect
earli
human
pregnanc
impact
bcrp
express
determin
role
bcrp
modul
migrat
potenti
evt
critic
establish
placent
earli
pregnanc
determin
impact
bacteri
mimick
lp
viral
mimick
singl
strand
rna
ssrna
infect
process
healthi
first
trimest
human
placent
tissu
collect
week
pregnanc
research
centr
women
infant
health
bio
bank
program
sinai
health
system
written
inform
consent
process
n
adher
polici
sinai
health
system
univers
toronto
research
ethic
board
first
trimest
human
placenta
week
elect
termin
singleton
pregnanc
use
set
extravil
explant
cultur
describ
earlier
briefli
small
cluster
column
cytotrophoblast
cct
villi
present
high
vascular
clear
white
tip
excis
dissect
microscop
tip
villi
clear
expos
cct
stem
cell
gentli
spread
matrigel
per
insert
phenol
red
free
becton
dickinson
bedford
usa
coat
transwel
insert
millipor
corp
billerica
usa
cultur
plate
serum
free
cultur
medium
supplement
normacin
invivogen
san
diego
ca
usa
ad
well
beneath
insert
keep
matrigel
moist
explant
allow
adher
matrigel
overnight
c
co
describ
earlier
next
day
medium
ad
insert
explant
incub
h
allow
format
evt
outgrowth
explant
outgrowth
observ
microscop
explant
exhibit
evt
sprout
includ
studi
knockdown
explant
media
supplement
transfect
complex
scrambl
control
nmollpleas
see
explant
photograph
time
zero
use
leica
camera
leica
microsystem
gmbh
wetzlar
germani
attach
dissect
microscop
photograph
taken
h
h
post
transfect
area
outgrowth
analyz
pictograph
use
imagej
softwar
percent
growth
calcul
divid
differ
final
initi
area
outgrowth
final
area
outgrowth
experi
perform
triplic
total
n
first
trimest
human
placenta
explant
tissu
attach
matrigel
collect
cut
membran
transwel
insert
wash
pb
fix
paraformaldehyd
h
tissu
dehydr
ascend
grade
ethanol
clear
xylen
embed
paraffin
section
mount
slide
immunohistochemistri
explant
process
immunohistochem
analysi
previous
describ
briefli
slide
deparaffin
rehydr
subject
antigen
retriev
sodium
citrat
block
dako
protein
block
dako
mississauga
canada
slide
incub
overnight
c
primari
antibodi
antimous
bcrp
millipor
billerica
usa
antimous
hlag
exbio
burlington
canada
antimous
dako
control
mous
rabbit
dako
ad
instead
primari
antibodi
incub
slide
wash
incub
correspond
biotinyl
secondari
antibodi
h
dako
section
wash
pb
min
incub
streptavidinhrp
min
dako
immunostain
detect
peroxidas
substrat
kit
dab
dako
slide
counterstain
hematoxylin
dehydr
ascend
concentr
ethanol
cover
slip
mount
medium
visual
undertaken
olympu
upright
motor
microscop
repres
imag
captur
use
olympu
digit
camera
olympu
tokyo
japan
first
trimest
human
placent
cell
line
kindli
provid
dr
charl
graham
queen
univers
cell
line
develop
use
first
trimest
evt
infect
simian
viru
larg
antigen
cell
cultur
perform
previous
describ
briefli
cell
cultur
roswel
park
memori
institut
medium
rpmi
thermo
fisher
scientif
wilmington
nc
usa
supplement
fetal
bovin
serum
fb
wisent
st
bruno
qc
canada
iuml
penicillin
iuml
streptomycin
co
c
invitrogen
canada
inc
burlington
canada
cell
seed
per
well
respect
plate
cultur
h
co
c
treat
lp
sigmaaldrich
st
loui
mo
usa
ssrna
invivogen
san
diego
ca
usa
h
dose
rang
previous
shown
elicit
trophoblast
inflammatori
respons
cell
media
collect
store
c
total
rna
protein
extract
enzymelink
immunosorb
assay
elisa
total
rna
isol
cell
line
use
rneasi
plu
univers
mini
kit
qiagen
toronto
canada
previous
describ
rna
concentr
puriti
assess
spectrophotomet
thermo
scientif
wilmington
nc
usa
experion
rna
stdsen
analysi
kit
biorad
mississauga
canada
respect
rna
reversetranscrib
cdna
use
iscript
revers
transcript
supermix
biorad
mrna
level
measur
qpcr
use
sybr
green
reagent
sigmaaldrich
cfx
realtim
system
tm
thermal
cycler
biorad
follow
cycl
condit
initi
denatur
c
min
follow
cycl
denatur
c
combin
anneal
extens
c
gene
express
normal
geometr
mean
select
refer
gene
includ
tatabind
protein
tbp
hypoxanthineguanin
phosphoribosyltransferas
hprt
stabl
express
lp
ssrna
treatment
cell
line
rel
express
target
gene
calcul
method
primer
sequenc
assess
gene
shown
tabl
tabl
list
primer
use
studi
sequenc
refer
western
blot
analysi
conduct
previous
describ
briefli
protein
isol
cultur
cell
extract
sonic
use
lysi
buffer
moll
trishcl
ph
sd
glycerol
ad
proteas
phosphatas
inhibitor
cocktail
thermo
scientif
protein
concentr
determin
pierc
bca
protein
assay
kit
thermo
scientif
protein
separ
electrophoresi
v
h
use
sd
polyacrylamid
gel
protein
transfer
min
polyvinyliden
fluorid
pvdf
membran
use
transblot
turbo
biorad
membran
block
skim
milk
h
room
temperatur
primari
antibodi
use
antirabbit
bcrp
dilut
abcam
toronto
canada
antirabbit
dilut
santa
cruz
biotechnolog
dalla
tx
usa
blot
incub
primari
antibodi
overnight
c
pvdf
membran
subsequ
incub
h
hrplink
antirabbit
secondari
antibodi
ge
healthcar
bioscienc
baie
durf
qc
canada
concentr
bcrp
proteinantibodi
complex
detect
incub
min
pvdf
membran
lamin
crescendo
western
hrp
substrat
millipor
oak
drive
ca
usa
chemiluminesc
detect
uv
use
chemidoc
tm
mp
imag
system
biorad
protein
band
intens
quantifi
use
imag
lab
tm
softwar
concentr
supernat
expos
lp
ssrna
veh
h
determin
use
human
elisa
develop
kit
invitrogen
thermo
scientif
wilmington
nc
usa
accord
manufactur
instruct
minimum
detect
limit
pgml
intraassay
variat
three
differ
stealth
sirna
duplex
design
synthes
shanghai
genepharma
shanghai
china
use
transient
inhibit
endogen
cell
sequenc
provid
tabl
cell
seed
densiti
cellswel
imagelock
micropl
bioscienc
inc
ann
arbor
mi
usa
follow
day
cell
transfect
use
lipofectamin
rnaimax
transfect
reagent
accord
manufactur
protocol
sirna
duplex
pool
cocktail
nm
equal
proport
equival
amount
scrambl
sirna
use
control
cell
harvest
h
post
transfect
rna
analysi
h
protein
migrat
analysi
determin
effect
bcrp
cell
migrat
cell
seed
imagelock
plate
next
day
cell
transfect
pool
scrambl
control
nc
incub
h
effect
knockdown
endogen
wound
creat
across
diamet
well
use
automat
wound
maker
essen
bioscienc
ann
arbor
mi
usa
cell
wash
twice
pb
remov
float
cell
cell
replenish
serumreduc
medium
optimem
incub
incucyt
system
essen
bioscienc
ann
arbor
mi
usa
wound
imag
everi
h
h
cell
migrat
determin
percent
wound
densiti
softwar
data
collect
everi
h
h
percentag
rel
wound
densiti
rwd
determin
incucyt
softwar
area
curv
auc
calcul
condit
mean
rwd
valu
compar
treatment
previous
describ
effect
pharmacolog
inhibit
bcrp
cell
migrat
assess
use
specif
inhibitor
sigmaaldrich
cell
seed
densiti
cell
per
well
imagelock
plate
treat
diluent
ethanol
vehicl
h
wound
cell
wound
wash
imag
describ
vehicl
maintain
medium
serum
reduc
migrat
assay
effect
infect
challeng
cell
migrat
assess
seed
cell
per
well
imagelock
cultur
plate
essen
bioscienc
ann
arbor
mi
usa
follow
day
cell
treat
lp
vehicl
water
h
similarli
cell
pretreat
ssrna
vehicl
water
h
treatment
replenish
wound
cell
wash
imag
analyz
incucyt
system
next
h
verifi
effect
bcrp
cell
migrat
due
alter
cell
migrat
due
secondari
effect
cell
prolifer
replic
condit
migrat
assay
regular
cultur
plate
subject
cell
prolifer
assess
use
incucyt
system
briefli
cell
seed
cultur
plate
next
day
cell
transfect
nm
pool
describ
previou
section
h
incub
incucyt
system
essen
bioscienc
ann
arbor
mi
usa
serumreduc
medium
optimem
similar
migrat
assay
cell
imag
everi
h
next
h
cell
prolifer
determin
percent
confluenc
softwar
data
gain
everi
h
h
area
curv
auc
calcul
condit
mean
confluenc
valu
compar
treatment
describ
previous
valid
effect
pharmacolog
inhibit
bcrp
effect
bacteri
viral
infect
challeng
cell
migrat
cell
prolifer
similarli
assess
use
approach
describ
determin
effect
bcrp
cell
prolifer
regular
growth
condit
transfectedtr
cell
describ
previou
section
h
incub
cell
complet
medium
fb
assess
cell
prolifer
incucyt
system
describ
analys
conduct
blind
experiment
condit
data
analys
perform
prism
version
graphpad
softwar
inc
san
diego
ca
usa
data
assess
normal
distribut
use
dagostino
pearson
shiparowilk
test
differ
migrat
prolifer
follow
pharmacolog
molecular
inhibit
bcrp
express
assess
unpair
ttest
differ
treatment
determin
oneway
anova
follow
newmankeul
posthoc
test
previous
report
bcrp
primarili
local
st
apic
membran
first
trimest
float
villi
lack
evt
column
studi
examin
bcrp
immunoloc
evt
explant
cultur
enrich
matrigel
sprout
migrationinvas
evt
tip
cct
identifi
immunohistochemistri
reveal
bcrp
immunostain
st
ct
cct
well
evt
invad
matrigel
tip
cct
figur
f
specif
trophoblast
lineag
histolog
identifi
compar
bcrp
signal
pair
serial
tissu
section
stain
cytokeratin
identifi
ct
cct
st
figur
b
hlag
identifi
evt
figur
respect
igg
control
show
immunostain
figur
h
first
valid
abil
reduc
mrna
protein
express
bcrp
cell
capabl
migrat
vitro
signific
downregul
bcrp
figur
figur
observ
follow
h
duplex
treatment
next
determin
specif
sirna
examin
mrna
level
relat
abc
transport
known
express
trophoblast
sirna
sequenc
uniqu
specif
mrna
sequenc
align
abc
transport
shown
figur
find
offtarget
effect
dose
durat
experi
figur
similarli
find
differ
protein
express
anoth
trophoblastenrich
abc
transport
figur
confirm
specif
procedur
cell
transient
transfect
oligo
nm
h
time
point
observ
signific
reduct
bcrp
protein
level
compar
scrambl
sirna
control
subject
woundscratch
assay
incucyt
tm
facilit
imag
analys
found
signific
p
increas
cell
migrat
transfect
cell
compar
scrambl
control
figur
first
valid
abil
reduc
mrna
protein
express
bcrp
cell
capabl
migrat
vitro
signific
downregul
bcrp
figur
figur
observ
follow
h
duplex
treatment
next
determin
specif
sirna
examin
mrna
level
relat
abc
transport
known
express
trophoblast
sirna
sequenc
uniqu
specif
mrna
sequenc
align
abc
transport
shown
figur
find
offtarget
effect
dose
durat
experi
figur
similarli
find
differ
protein
express
anoth
trophoblastenrich
abc
transport
figur
confirm
specif
procedur
cell
transient
transfect
oligo
nm
h
time
point
observ
signific
reduct
bcrp
protein
level
compar
scrambl
sirna
control
subject
woundscratch
assay
incucyt
tm
facilit
imag
analys
found
signific
p
increas
cell
migrat
transfect
cell
compar
scrambl
control
figur
chang
cell
prolifer
similar
cultur
condit
figur
e
supplementari
figur
strongli
suggest
bcrp
inhibit
evt
migrat
inhibit
bcrp
function
use
bcrp
specif
inhibitor
result
similar
signific
increas
p
trophoblast
migrat
figur
h
alter
prolifer
figur
j
confirm
bcrp
inhibit
evt
migrat
lp
treatment
h
cell
significantli
p
decreas
mrna
express
figur
ssrna
exposur
repress
mrna
low
high
dose
p
p
figur
respect
sinc
cytokin
chemokin
releas
primari
system
respons
bacteri
viral
infect
evalu
lp
ssrna
inflammatori
respons
examin
induct
lp
treatment
increas
level
express
interleukin
il
mrna
figur
figur
cc
motif
chemokin
ligand
figur
mrna
high
dose
ssrna
treatment
increas
level
figur
mrna
figur
high
dose
wherea
mrna
express
figur
remain
unchang
treatment
similar
mrna
express
found
signific
decreas
bcrp
protein
follow
h
exposur
low
high
dose
lp
ssrna
figur
b
also
signific
increas
level
cultur
media
h
exposur
low
dose
lp
p
high
dose
ssrna
p
chang
level
figur
f
bcrp
express
cell
lp
treatment
h
cell
significantli
p
decreas
mrna
express
figur
ssrna
exposur
repress
mrna
low
high
dose
p
p
figur
respect
sinc
cytokin
chemokin
releas
primari
system
respons
bacteri
viral
infect
evalu
lp
ssrna
inflammatori
respons
examin
induct
lp
treatment
increas
level
express
interleukin
il
mrna
figur
figur
cc
motif
chemokin
ligand
figur
mrna
high
dose
ssrna
treatment
increas
level
figur
mrna
figur
high
dose
wherea
mrna
express
figur
remain
unchang
treatment
similar
mrna
express
found
signific
decreas
bcrp
protein
follow
h
exposur
low
high
dose
lp
ssrna
figur
b
also
signific
increas
level
cultur
media
h
exposur
low
dose
lp
p
high
dose
ssrna
p
chang
level
figur
hprt
tbp
use
normal
data
express
mean
sem
n
per
group
statist
differ
test
oneway
anova
follow
newmankeul
posthoc
test
p
p
p
versu
veh
hprt
tbp
use
normal
data
express
mean
sem
n
per
group
statist
differ
test
oneway
anova
follow
newmankeul
posthoc
test
p
p
p
versu
veh
sinc
lp
ssrna
decreas
bcrp
express
evtlik
cell
undertook
seri
experi
determin
lp
ssrna
treatment
affect
evt
migrat
woundscratch
assay
reveal
cell
expos
low
high
dose
lp
figur
c
ssrna
figur
g
exhibit
significantli
higher
wound
densiti
cell
treat
vehicl
analysi
data
area
curv
auc
show
signific
p
increas
migrat
cell
expos
lp
figur
sinc
lp
ssrna
decreas
bcrp
express
evtlik
cell
undertook
seri
experi
determin
lp
ssrna
treatment
affect
evt
migrat
woundscratch
assay
reveal
cell
expos
low
high
dose
lp
figur
c
ssrna
figur
g
exhibit
significantli
higher
wound
densiti
cell
treat
vehicl
analysi
data
area
curv
auc
show
signific
p
increas
migrat
cell
expos
lp
figur
ssrna
figur
chang
cell
prolifer
figur
h
supplementari
figur
use
human
placent
explant
exvivo
model
human
placenta
determin
physiolog
signific
bcrp
evt
function
placent
follow
transfer
first
trimest
human
placent
explant
matrigel
coat
transwel
insert
villi
visibl
sign
evt
outgrowth
treat
control
oligo
assess
time
transfect
h
h
posttransfect
evt
migrat
determin
compar
percent
evt
outgrowth
control
versu
treat
explant
substanti
reduct
bcrp
express
placent
villi
treat
explant
compar
control
determin
immunohistochemistri
figur
silenc
result
significantli
greater
expans
migrat
invas
evt
outgrowth
matrigel
h
p
h
p
compar
control
figur
b
hlag
use
marker
evt
verifi
migrat
invas
evt
across
matrigel
versu
control
explant
use
trophoblast
marker
figur
use
human
placent
explant
exvivo
model
human
placenta
determin
physiolog
signific
bcrp
evt
function
placent
follow
transfer
first
trimest
human
placent
explant
matrigel
coat
transwel
insert
villi
visibl
sign
evt
outgrowth
treat
control
oligo
assess
time
transfect
h
h
posttransfect
evt
migrat
determin
compar
percent
evt
outgrowth
control
versu
treat
explant
substanti
reduct
bcrp
express
placent
villi
treat
explant
compar
control
determin
immunohistochemistri
figur
silenc
result
significantli
greater
expans
migrat
invas
evt
outgrowth
matrigel
h
p
h
p
compar
control
figur
b
hlag
use
marker
evt
verifi
migrat
invas
evt
across
matrigel
versu
control
explant
use
trophoblast
marker
figur
studi
provid
new
insight
regul
evt
migrat
earli
placent
develop
report
first
time
bcrp
well
known
role
efflux
transport
inhibit
evt
cell
migrat
evtlik
cell
first
trimest
deriv
evt
addit
present
st
bcrp
also
express
cct
evt
human
placenta
first
trimest
implic
role
evt
function
inhibit
bcrp
increas
cell
migrat
evtlik
cell
line
h
without
affect
prolifer
also
demonstr
lp
ssrna
exposur
decreas
bcrp
express
evt
stimul
evt
migrat
togeth
data
suggest
bcrp
function
inhibitor
evt
migrat
infect
may
lead
increas
evt
migrat
present
studi
effect
knock
bcrp
express
use
sirna
duplex
technolog
result
increas
migrat
evt
cell
alter
prolifer
index
import
note
use
novel
autom
approach
monitor
analyz
migrat
evt
cell
calcul
wound
densiti
area
curv
gener
data
record
everi
h
h
use
technolog
pharmacolog
inhibit
bcrp
result
similar
outcom
interestingli
contrast
report
cancer
cell
line
suggest
bcrp
increas
migrat
glioma
pancreat
cancer
cell
inhibit
prolifer
epitheliallik
cancer
cell
line
differ
may
result
fact
cancer
cell
line
deriv
human
tumor
wherea
cell
deriv
physiolog
evt
thu
illustr
differ
action
bcrp
modul
cell
migrat
physiolog
neoplast
phenotyp
divers
cancer
cell
may
commonli
exhibit
increas
basal
express
bcrp
import
mechan
confer
multidrug
resist
chemotherapeut
drug
postul
adapt
rearrang
intracellular
signal
pathway
undertaken
malign
cell
promot
invas
previou
studi
report
pglycoprotein
pgp
anoth
abc
transport
relat
stmediat
fetal
protect
reduc
cell
prolifer
invas
contrast
action
bcrp
pgp
earli
placent
requir
investig
attract
specul
pgp
drive
placent
enhanc
evt
migrationinvas
bcrp
like
control
extent
evt
penetr
within
decidua
mechan
bcrp
modul
evt
migrat
remain
determin
bcrp
may
regul
transport
activ
substrat
critic
cell
migrat
extracellular
matrix
ecm
adhes
molecul
pgp
bcrp
known
interact
modul
cancer
cell
migrationinvas
also
possibl
pgp
bcrp
share
mediat
control
evt
cell
migrat
exampl
hyaluron
acid
ha
mediat
cellcellcellmatrix
adhes
henc
affect
cell
migrat
document
cell
surfac
evt
import
mediat
evt
invas
string
databas
proteinprotein
interact
indic
interact
bcrp
http
stringdborgcginetworkpl
taskidokgqmllrxdfw
base
possibl
specul
bcrp
compet
pgp
bind
interfer
mediat
adhes
properti
evt
henc
imped
evt
migrationinvas
possibl
requir
investig
present
studi
lp
treatment
model
bacteri
infect
via
activ
decreas
mrna
bcrp
protein
express
cell
indic
bacteri
infect
earli
human
pregnanc
potenti
affect
evt
migrat
modul
bcrp
express
pattern
bcrp
inhibit
consist
previou
report
show
bcrp
express
decreas
h
exposur
first
trimest
human
explant
lp
rat
previou
studi
shown
lp
downregul
placent
mrna
studi
investig
effect
lp
bcrp
activ
howev
midgest
lp
inhibit
pgp
encod
rodent
efflux
transport
mous
placenta
togeth
studi
suggest
regul
placent
lp
gestat
agedepend
importantli
also
indic
bacteri
infect
potenti
compromis
normal
evt
migrat
fetal
protect
inhibit
bcrp
express
evt
st
respect
exposur
ssrna
model
viral
infect
induc
trophoblast
proinflammatori
respons
via
activ
signal
pathway
also
decreas
mrna
bcrp
protein
express
evt
indic
viral
infect
may
via
decreas
express
bcrp
disrupt
normal
evt
migrat
previou
report
ssrna
modul
placent
bcrp
express
though
poli
c
synthet
analog
doubl
strand
rna
dsrna
act
via
activ
shown
decreas
third
trimest
human
placent
explant
late
gestat
rat
placenta
studi
assess
effect
poli
c
bcrp
function
howev
poli
c
inhibit
pgp
activ
fetal
mous
bloodbrain
barrier
alter
placent
pgp
function
suggest
effect
dsrna
viral
infect
pgp
mediat
fetal
protect
tissu
barrier
depend
futur
studi
investig
role
ssrna
regul
pgp
bcrp
function
develop
barrier
warrant
matern
infect
singlestrand
rna
virus
capabl
cross
placent
barrier
ie
zika
zikv
rubella
virus
elicit
sever
obstetr
outcom
includ
microencephali
cerebr
palsi
intellectu
disabl
sequela
present
studi
show
infect
ssrna
also
includ
influenza
flu
viru
rhinoviru
common
cold
viru
retroviru
hiv
coronaviru
upperrespiratori
ill
viru
potter
et
al
luo
et
al
earlypregn
potenti
disrupt
normal
evt
migrat
ultim
placent
placent
function
fetal
develop
context
human
placenta
infect
zikv
exhibit
mark
villou
immatur
increas
ratio
syncyti
sprout
syncyti
nuclei
aggreg
outer
trophoblast
wall
provid
patholog
evid
uteroplacent
malperfus
typic
associ
derang
evt
migrat
decidu
endometrium
result
poor
myometri
spiral
arteri
remodel
reperfus
viral
bacteri
parasit
infect
relat
enhanc
likelihood
pe
modul
proinflammatori
cytokin
oxid
stress
antiangiogen
protein
earli
matern
fetal
interfac
shown
ssrna
increas
migrat
importantli
previou
studi
investig
impact
ssrna
trophoblast
evt
migrat
migrat
normal
somat
cell
howev
studi
cancer
cell
shown
ssrna
affect
migrat
invas
melanoma
cell
liu
et
al
present
studi
provid
evid
bcrp
inhibit
evt
migrat
repress
bacteri
viral
infect
challeng
result
suggest
downregul
bcrp
may
involv
cellular
pathway
infect
increas
evt
cell
migrat
howev
rule
abc
transport
modul
lp
ssrna
evt
cultur
system
may
contribut
increas
migrat
rate
herein
observ
follow
infect
challeng
bcrp
highli
respons
number
cytokin
present
studi
shown
lp
ssrna
increas
mrna
level
secret
mrna
protein
suggest
cytokin
inhibit
addit
inhibitori
effect
bcrp
express
evt
hypothesi
requir
investig
conclus
identifi
novel
role
bcrp
earli
placent
figur
present
studi
demonstr
evt
express
bcrp
bcrp
limit
evt
migrat
bacteri
viral
infect
result
decreas
bcrp
evt
concomit
increas
evt
migrat
suggest
bcrp
play
role
infectionrel
alter
evt
function
mechan
may
underli
etiolog
pregnanc
complic
conclus
identifi
novel
role
bcrp
earli
placent
figur
present
studi
demonstr
evt
express
bcrp
bcrp
limit
evt
migrat
bacteri
viral
infect
result
decreas
bcrp
evt
concomit
increas
evt
migrat
suggest
bcrp
play
role
infectionrel
alter
evt
function
mechan
may
underli
etiolog
pregnanc
complic
supplementari
materi
follow
avail
onlin
figur
repres
imag
cell
prolifer
assay
follow
scrambl
sirna
veh
exposur
h
n
scale
bar
figur
repres
imag
cell
prolifer
assay
follow
lp
ssrna
veh
exposur
h
n
scale
bar
acknowledg
author
thank
donor
research
centr
women
infant
health
biobank
program
lunenfeldtanenbaum
research
institut
mshuhn
dept
obstetr
gynecolog
human
specimen
use
studi
http
biobanklunenfeldca
also
thank
charl
graham
provid
cell
carolin
dunk
assist
placent
explant
cultur
author
also
thank
vanya
peltekova
ontario
institut
cancer
research
provid
train
access
incucyt
studi
miss
jittanan
nakpu
illustr
figur
figur
repres
imag
cell
prolifer
assay
follow
scrambl
sirna
veh
exposur
h
n
scale
bar
figur
repres
imag
cell
prolifer
assay
follow
lp
ssrna
veh
exposur
h
n
scale
bar
